𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind comparison of paroxetine and fluvoxamine in major depression

✍ Scribed by Ansseau, M.; Gabriëls, A.; Loyens, J.; Bartholomé, F.; Evrard, J.; De Nayer, A.; Linhart, R.; Wirtz, J.; Bruynoghe, F.; Surinx, K.

Book ID
123041675
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
148 KB
Volume
3
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled comparison of paroxetine and
Controlled comparison of paroxetine and fluvoxamine in major depression
✍ M. Ansseau; A. Gabriëls; J. Loyens; F. Bartholomé; J. L. Evrard; A. De Nayer; R. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

A multicentre study compared the antidepressant efficacy and the tolerance of two selective serotonin reuptake inhibitors, paroxetine (20-30 mg/d) and fluvoxamine (50-200 mg/d) in two parallel groups of respectively 56 and 64 patients with major depression, as defined by DSM-III-R criteria. The dura

Fluvoxamine versus fluoxetine in major d
Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison
✍ Jean Dalery; Adriaan Honig 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract A double‐blind, multinational study was conducted to compare the efficacy and safety of fluvoxamine and fluoxetine in outpatients with major depressive episode; 184 patients were randomised to fluvoxamine (100 mg/day) or fluoxetine (20 mg/day) for 6 weeks. Both drugs were effective and